John Cannon

1.7k total citations
36 papers, 672 citations indexed

About

John Cannon is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, John Cannon has authored 36 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 17 papers in Cardiology and Cardiovascular Medicine and 9 papers in Surgery. Recurrent topics in John Cannon's work include Pulmonary Hypertension Research and Treatments (23 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Vascular Anomalies and Treatments (7 papers). John Cannon is often cited by papers focused on Pulmonary Hypertension Research and Treatments (23 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Vascular Anomalies and Treatments (7 papers). John Cannon collaborates with scholars based in United Kingdom, United States and Canada. John Cannon's co-authors include Joanna Pepke‐Żaba, Mark Toshner, Dolores Taboada, David P. Jenkins, Karen Sheares, Choo Ng, Steven Tsui, Mark R. Fahey, John Dunning and Marius Berman and has published in prestigious journals such as Anesthesiology, European Respiratory Journal and Journal of Investigative Dermatology.

In The Last Decade

John Cannon

35 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Cannon United Kingdom 12 411 353 191 143 115 36 672
Francisco S. Lozano Spain 13 99 0.2× 109 0.3× 193 1.0× 266 1.9× 23 0.2× 45 493
Keith Abe United States 9 53 0.1× 510 1.4× 395 2.1× 116 0.8× 13 0.1× 14 762
John Caplin United Kingdom 12 86 0.2× 225 0.6× 33 0.2× 87 0.6× 44 0.4× 29 404
Peter H. Norman United States 16 160 0.4× 97 0.3× 33 0.2× 334 2.3× 219 1.9× 39 749
Mitsuro Kurose Japan 10 174 0.4× 649 1.8× 95 0.5× 123 0.9× 8 0.1× 24 844
Thomas F. Rehring United States 14 268 0.7× 219 0.6× 33 0.2× 258 1.8× 5 0.0× 39 616
P Maiolino Italy 15 340 0.8× 319 0.9× 15 0.1× 173 1.2× 8 0.1× 45 717
Gautam Sreeram United States 13 51 0.1× 174 0.5× 36 0.2× 153 1.1× 14 0.1× 16 492
Aurel C. Cernaianu United States 15 208 0.5× 180 0.5× 12 0.1× 285 2.0× 43 0.4× 33 621
Jussi Rimpiläinen Finland 14 104 0.3× 230 0.7× 20 0.1× 232 1.6× 5 0.0× 32 565

Countries citing papers authored by John Cannon

Since Specialization
Citations

This map shows the geographic impact of John Cannon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Cannon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Cannon more than expected).

Fields of papers citing papers by John Cannon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Cannon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Cannon. The network helps show where John Cannon may publish in the future.

Co-authorship network of co-authors of John Cannon

This figure shows the co-authorship network connecting the top 25 collaborators of John Cannon. A scholar is included among the top collaborators of John Cannon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Cannon. John Cannon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stubbs, Harrison, John Cannon, Chloe Roddis, et al.. (2024). Sendaway capillary NT-proBNP in pulmonary hypertension. BMJ Open Respiratory Research. 11(1). e002124–e002124. 2 indexed citations
2.
Montani, David, José M. Cifrián, Hilario Nunès, et al.. (2024). Unmet need in pulmonary hypertension-associated interstitial lung disease (PH-ILD): a clinician survey of real-world management of PH-ILD in Europe. ERJ Open Research. 10(4). 39–2024. 2 indexed citations
3.
Chiu, Stephen, Katherine Bunclark, Hakim Ghani, et al.. (2024). Impact of preoperative body mass index on long-term survival, quality of life, and functional outcomes after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: Results from the UK National Cohort. The Journal of Heart and Lung Transplantation. 44(1). 25–32. 2 indexed citations
4.
Sheares, Karen, Mark Toshner, Katherine Bunclark, et al.. (2023). Balloon pulmonary angioplasty outcomes in patients previously treated by pulmonary endarterectomy surgery are inferior to those of inoperable patients. Pulmonary Circulation. 13(3). e12265–e12265. 4 indexed citations
5.
Swietlik, Emilia M., Alice Michael, Gary Polwarth, et al.. (2023). Natural history of chronic thromboembolic pulmonary disease with no or mild pulmonary hypertension. The Journal of Heart and Lung Transplantation. 42(9). 1275–1285. 12 indexed citations
6.
Hadinnapola, Charaka, Mark Southwood, Jules Hernández‐Sánchez, et al.. (2022). Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH—Results from a prospective discovery and validation biomarker study. The Journal of Heart and Lung Transplantation. 42(3). 398–405. 9 indexed citations
7.
Sheares, Karen, Mark Toshner, Dolores Taboada, et al.. (2022). Acute lung injury after balloon pulmonary angioplasty results in a similar haemodynamic response and possible clinical advantage at follow‐up. Pulmonary Circulation. 12(4). e12166–e12166. 2 indexed citations
8.
Newman, Joseph, David P. Jenkins, Choo Ng, et al.. (2021). Rising COVID-19 related acute pulmonary emboli but falling national chronic thromboembolic pulmonary hypertension referrals from a large national dataset. ERJ Open Research. 7(4). 431–2021. 9 indexed citations
9.
Coghlan, Gerry, John Cannon, Dolores Taboada, et al.. (2021). Serial right heart catheter assessment between balloon pulmonary angioplasty sessions identify procedural factors that influence response to treatment. The Journal of Heart and Lung Transplantation. 40(10). 1223–1234. 21 indexed citations
10.
Newnham, Michael, Katherine Bunclark, John Cannon, et al.. (2020). CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. European Respiratory Journal. 56(4). 1902096–1902096. 34 indexed citations
11.
Swietlik, Emilia M., Pavandeep Ghataorhe, John Wharton, et al.. (2020). Plasma metabolomics exhibit response to therapy in chronic thromboembolic pulmonary hypertension. European Respiratory Journal. 57(4). 2003201–2003201. 31 indexed citations
12.
Bunclark, Katherine, Michael Newnham, Yi‐Da Chiu, et al.. (2019). A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension. Journal of Thrombosis and Haemostasis. 18(1). 114–122. 71 indexed citations
13.
Cannon, John & Joanna Pepke‐Żaba. (2014). Riociguat for pulmonary hypertension. Expert Review of Clinical Pharmacology. 7(3). 259–270. 9 indexed citations
14.
Taboada, Dolores, Joanna Pepke‐Żaba, David P. Jenkins, et al.. (2014). Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease. European Respiratory Journal. 44(6). 1635–1645. 164 indexed citations
15.
Cannon, John, et al.. (2005). Intrapulmonary shunting and hepatopulmonary syndrome. British Journal of Hospital Medicine. 66(5). 312–313.
16.
Mollison, Karl W., Thomas A. Fey, Donna M. Gauvin, et al.. (1999). A Macrolactam Inhibitor of T Helper Type 1 and T Helper Type 2 Cytokine Biosynthesis for Topical Treatment of Inflammatory Skin Diseases1. Journal of Investigative Dermatology. 112(5). 729–738. 10 indexed citations
17.
Searle, Norman R., et al.. (1999). A two-center study evaluating the hemodynamic and pharmacodynamic effects of cisatracurium and vecuronium in patients undergoing coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia. 13(1). 20–25. 5 indexed citations
18.
Cannon, John, et al.. (1991). Pneumocephalus following attempted epidural anaesthesia. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 38(6). 772–774. 42 indexed citations
19.
Cannon, John, Mark R. Fahey, Jonathan Moss, & Ronald D. Miller. (1988). Large doses of vecuronium and plasma histamine concentrations. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 35(4). 350–353. 18 indexed citations
20.
Cannon, John, Mark R. Fahey, Kay Castagnoli, et al.. (1987). Continuous Infusion of Vecuronium. Anesthesiology. 67(4). 503–506. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francisco S. Lozano Breakdown of academic impact, for papers by Keith Abe Breakdown of academic impact, for papers by John Caplin Breakdown of academic impact, for papers by Peter H. Norman Breakdown of academic impact, for papers by Mitsuro Kurose Breakdown of academic impact, for papers by Thomas F. Rehring Breakdown of academic impact, for papers by P Maiolino Breakdown of academic impact, for papers by Gautam Sreeram Breakdown of academic impact, for papers by Aurel C. Cernaianu Breakdown of academic impact, for papers by Jussi Rimpiläinen
Rankless by CCL
2026